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Summary
Innate lymphoid cells (ILCs) were identified principally as non-T-cell
sources of key cytokines, able to provide rapid and early production of
these molecules in the support of tissue homeostasis, repair and response
to infection. As our understanding of these cells has developed, it has
become evident that ILCs can impact on lymphocytes through a range of
mechanisms. Hence, an exciting area of research has evolved in determin-
ing the extent to which ILCs may regulate adaptive immune responses.
This review will focus initially on our current understanding of where ILC
populations are located and what this means for potential cellular interac-
tions. Mechanisms underpinning such interactions and how they may
contribute to controlling adaptive immunity will then be considered.
Keywords: innate lymphoid cells; memory; spleen and lymph nodes; T
cells.
Introduction
Cells of the innate lymphoid cell (ILC) family have
emerged in recent years as important players in the main-
tenance of tissue defence, repair and homeostasis, particu-
larly at mucosal sites.1 Since their formal description in
2013,2 enormous progress has been made in characteriz-
ing these cells in both mice and humans and in under-
standing their developmental requirements. We now
know a lot of what they can do; however, determining
their contribution to immune responses in vivo, as part
of an intact immune system, remains a substantial chal-
lenge. Multiple lines of evidence indicate important roles
for these cells in the regulation of adaptive responses,
particularly those of CD4+ T cells.3–6 Yet fundamental
questions remain concerning ILC contributions in vivo to
adaptive immunity, notably regarding the precise mecha-
nisms involved, but also where key cellular interactions
occur and at what stage in the response. Progress has
been limited by the lack of suitable in vivo models avail-
able to pinpoint ILC roles. With the emergence of supe-
rior approaches to test ILC functions,4 substantial
headway in this area of research should be anticipated.
Beyond an initial overview of ILC biology (many excel-
lent reviews have been recently published including refs
1,7,8), here I will review the current understanding of
ILC location within tissues, how this relates to their cellu-
lar interactions, and mechanisms through which ILCs
may contribute to initiating, sustaining and even limiting
adaptive immune responses.
Overview of ILC groups
Innate lymphoid cells were defined as cells derived from a
common lymphoid progenitor that are lymphoid in mor-
phology but distinct from B and T cells, as they do not
depend upon recombination activation gene-mediated
gene segment rearrangement to develop.2 Based upon the
cytokines produced and the transcription factors control-
ling their development, three distinct groups were
described mirroring several of the known effector CD4+
T-cell subsets. Hence the group 1 ILCs (ILC1) contain
those cells able to produce the T helper type 1 (Th1)
cell-associated cytokines interferon-c and tumour necrosis
factor a and are at least partially dependent upon the
transcription factor T-box factor expressed in T cells
(T-bet).9 One major lineage within the ILC1 group are
natural killer (NK) cells, recognized for many years as key
cells in responding to viral infection and tumour surveil-
lance.10 Although NK cells can be further split into
several subsets, a second lineage distinct from NK cells
does not require or express the transcription factor
Abbreviations: APCs, antigen-presenting cells; DCs, dendritic cells; GATA-3, GATA-binding protein 3; ILCs, innate lymphoid
cells; IL, interleukin; NK, natural killer; ROR, retinoic-acid-receptor-related orphan receptor; T-bet, T-box factor expressed in T
cells; Th, T helper
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Eomesodermin, a close homologue of T-bet.9 These
Eomesodermin-negative ILC1 appear to respond to intra-
cellular infections.11,12 The group 2 ILCs (ILC2) respond
to signals including interleukin 25 (IL-25), IL-33 and thy-
mic stromal lymphopoietin to produce some or all of the
Th2-associated cytokines IL-4, IL-5, IL-9, IL-13, so pro-
moting not only anti-helminth responses but also allergic
inflammation.13–17 At least two subsets of ILC2 have been
described to date.18 Although ILC2 were first recognized
as being GATA-binding protein 3 (GATA-3) dependent,19
akin to Th2 cells,20 all ILC populations with the exception
of conventional NK cells require GATA-3 for their devel-
opment.21,22 GATA-3 expression is maintained at high
levels in ILC2, unlike other ILC populations, and ILC2
remain dependent upon continued GATA-3 expression
for their function.19 ILC2 development is also dependent
upon the transcription factors retinoic-acid-receptor-
related orphan receptor (ROR)a,23 Bcl11b24 and ETS-1.25
The third group of ILCs (ILC3) were defined as those
cells able to produce the cytokines IL-17A and IL-22 and
dependent upon the transcription factor RORct for their
development.26–29 ILC3s are diverse in terms of known
functions, including lymphoid organogenesis, antibacterial
immunity and epithelial barrier protection.26,30–32 In the
adult, several phenotypically distinct RORct-expressing
ILC populations have been described that may all con-
tribute to mucosal barrier integrity through production
of IL-22 and Csf-2 (granulocyte–macrophage colony-sti-
mulating factor), principally in response to IL-23 and
augmented by IL-1b and TL1a.32–34 Despite being
expressed at low levels relative to ILC2, continued GATA-
3 expression is required for at least some ILC3
functions.35 Surprisingly, the group-defining transcription
factor RORct may not be required for several important
ILC3 functions, in contrast to Th17 cells.36
Innate lymphoid cells are derived from a common ILC
precursor,8 further differentiated than common lymphoid
progenitors (such that it cannot give rise to B and T
cells) and identified through its high expression of CD127
and a4b7.
11,37,38 The common ILC precursor differentiates
into further precursor populations that retain the ability
to form some ILC populations but not others.37
ILC microenvironments
Understanding the location of ILCs within tissue and the
potential cellular interactions of these cells is essential for
understanding the in vivo functions of these cells.
Through flow cytometric approaches ILCs have been
described in a range of tissues; however, there are few
precise details of their positioning with regard to other
cell types. Dynamic in vivo imaging of ILC populations
remains even more scarce,39 so much of our understand-
ing of ILC location and their cellular interactions reflect a
limited number of immunofluorescence snap shots.26,40,41
Using flow cytometry, ILCs are identified through an
extensive panel of antibodies, so their identification by
standard immunofluorescent techniques is challenging.
This has limited identification of some populations such
as Eomesodermin-negative ILC1. ILC3 populations have
been most studied, aided by tools that enable robust
detection of RORct.26,40,42,43 To date, such experiments
show that ILC populations are not evenly distributed
throughout tissue, rather they are concentrated in specific
regions, which one must assume relates to their
functions.
Secondary lymphoid tissues
When considering ILC contributions to adaptive immu-
nity, an obvious point is that these cells have been
described within all secondary lymphoid tissues, the key
sites for initiating adaptive immune responses, particu-
larly those of B and CD4+ T cells.44 However, the funda-
mental question remains – what do they actually do in
these tissues? Compared with mucosal barrier tissues such
as the intestine, the frequency of ILCs relative to other
haematopoietic cells is very low in secondary lymphoid
tissue. Of course, the vast majority of CD45+ cells in
lymph nodes and spleen are naive lymphocytes recirculat-
ing through the tissue in search of cognate antigen, hence
all non-lymphocyte populations are rare in such tissues.
Immunofluorescent studies showed that ILC3 (defined as
RORct+ CD3 cells) are only present within a very dis-
tinct region of lymph nodes, the interfollicular region and
interface between the B-cell and T-cell zones.40,41 Evi-
dence to date also indicate that ILC2 reside in this region
of lymph nodes.41 This specific location is noteworthy
because it is a key region through which lymphocytes, as
well as other immune cells, traffic during different stages
of adaptive responses.45,46 Hence by residing here, ILC3
clearly have the potential to impact on multiple stages of
B-cell and T-cell responses. As outlined in Fig. 1, acti-
vated dendritic cells (DCs) entering the lymph node via
the afferent lymphatics pass through the interfollicular
spaces on their way to the T zone.45 Activated B and
CD4+ T cells specifically move to the interfollicular region
during the early stages of the response and key
differentiation events appear to be initiated here.46 Mem-
ory B- and T-cell populations recirculate through
secondary lymphoid tissue and also probably pass
through this region.47–49
In other murine secondary lymphoid tissues, ILC3 are
located within analogous locations of cellular trafficking,
for example the marginal zone bridging channels of the
splenic white pulp and the edge of the B-cell follicles in
Peyer’s patches.38,40,50 Furthermore, in human spleen and
lymph nodes, ILC3 also appear to be located in compara-
ble locations.51,52 Hence, although rare, ILCs appear to
reside specifically within regions of secondary lymphoid
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tissue suggestive of common functions in B-cell and
T-cell responses. Although in most tissues ILCs appear to
be excluded from both the inner T zone and B-cell follicle
environments, an exception to this is in the isolated lym-
phoid follicles of the gut, where ILC3 are clearly located
throughout the follicle and contribute to T-cell-indepen-
dent switching to IgA via lymphotoxin a1b2.
53,54 Among
ILC1 populations, NK cells have been described in the
splenic red pulp and T zone of lymph nodes although
their location can change in response to infection.55,56
Thus, although ILC2 and ILC3 may occupy similar loca-
tions within secondary lymphoid tissue, to date, members
of the ILC1 group have been detected in different regions
of this tissue.
ILCs in ‘non-lymphoid’ tissues
The positioning of ILCs in secondary lymphoid tissue is
suggestive of roles in adaptive immune responses, but
ILCs are clearly both more numerous and more frequent
relative to other haematopoietic cells in non-lymphoid
tissues, particularly within mucosal barriers such as the
lung and intestine, but also in tissues such as skin and
fat. Imaging of cells in such tissues is often significantly
more challenging than in secondary lymphoid tissue, and
clear data on where ILC populations reside remains pat-
chy. Many tissues described as ‘non-lymphoid’ contain
organized patches of lymphoid cells, best characterized in
the intestine,57 but also present at other sites, for example
in adipose tissue as fat-associated lymphoid clusters.14,58
Subgroups of ILCs may reside at different locations, facil-
itating specific functions. For example, ILC3 populations
associated with lymphoid tissues are almost all
NKp46 MHCII+ whereas NKp46+ MHCII ILC3 appear
to reside outside gut associated lymphoid tissues in the
small intestine lamina propria.42 Within the lung and
skin, it appears that ILCs are scattered within the tissue
and probably only become concentrated in distinct sites
after insult or inflammation.6,59,60 It remains to be clearly
demonstrated whether ILC populations in adipose tissue
are mostly within fat-associated lymphoid clusters or
located outside these structures.
What is the relationship between ILC populations in
tissue and the secondary lymphoid tissues that drain these
sites? Studies using parabiotic mice concluded that ILC
are tissue-resident cells that are maintained and expanded
locally.61 Differentiation to ILC precursor populations
occurs in the fetal liver and bone marrow,37,62 before
these cells seed peripheral tissues, and most appear to
complete their maturation at these sites.62–64 Recent
B cell 
follicle
T zone
Lymph
Afferent
lymphatics
Subcapsular
sinus
Lymph
node
capsule
ILC2 Antigen-specific T cell
ILC3 Antigen-specific B cell
Dendritic cell (DC) High endothelial venule (HEV)
Subcapsular sinus
macrophage
Memory cell
ILCs reside in the
interfollicular and
subcapsular region
Activated B and T cells
migrate to the
interfollicular region
after initial priming
Activated dendritic cells
travel through
interfollicular region
to the T zone
Memory B and T cells
reside and recirculate
through interfollicular and
subcapsular sinus region
Figure 1. Innate lymphoid cells from groups 2 (ILC2) and 3 (ILC3) reside at key sites of lymphocyte traffic in secondary lymphoid tissue. Car-
toon showing the location of ILC2 and ILC3 populations in lymph nodes40,41 where both populations reside in the interfollicular spaces and at
the interface of the B-cell and T-cell zones. This location facilitates potential interactions with (1) subscapular sinus macrophages located in the
immediate vicinity; (2) activated dendritic cells (DCs) entering through the afferent lymph; (3) activated lymphocytes migrating to this region;
(4) memory cells recirculating through the tissue.
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experiments using photoconvertible mice offer some evi-
dence that ILC populations within lymph nodes may be
supplemented by ILCs trafficking from local tissue.41 In
summary, current evidence indicates that the majority of
ILCs reside within non-lymphoid tissues; however, clear
populations exist in lymphoid tissues. Questions remain
concerning the extent to which those ILCs in secondary
lymphoid tissues are populated by cells trafficking from
local tissues. Having drained to these sites, can ILCs then
re-enter the circulation? Based on parabiosis studies, if
this occurs it involves only small numbers of ILCs.61 The
specific functions that might be served by these small
migratory ILC populations are currently unclear.
How can ILCs regulate adaptive immune
responses?
In discussing how ILC populations impact on adaptive
immune responses, it is clear that many questions remain
in our understanding of their precise roles. This reflects the
limitations of current in vivo models and the relatively few
investigations in this area. Here I will review how ILC pop-
ulations may affect adaptive immune responses, focusing
on specific examples where robust data exist. Simplistically,
the roles identified to date can be split into indirect effects
on lymphocytes mediated by other cells types and direct
interactions with B and T cells. These possible interactions
are summarized in Fig. 2.
ILCs: middle men in regulating adaptive immune
responses?
Innate lymphoid cell cytokine production clearly con-
tributes to regulating tissue protection through innate
mechanisms.12,65 Given their rapid and substantial pro-
duction of some cytokines, ILCs also probably contribute
to driving T helper cell differentiation. For example NK
cell production of interferon-c may contribute towards
Th1 differentiation, ILC2 appear to be a critical source of
IL-4 in driving Th2 differentiation following helminth
infection.66,67 Where further progress has been made, is
in understanding how ILCs can influence other local
innate populations that then impact on the success of the
lymphocyte response. Hence, recent evidence indicates
the ILCs serve as middle-men, responding to signals in
the tissue and helping to orchestrate progression of the
adaptive response, both at the site of insult, and in the
draining secondary lymphoid tissue. Within the lung, it is
now evident that ILC2 impact on several stages of the
Th2 CD4+ T-cell response to allergens through interac-
tions with DC populations. In establishing the initial
response, ILC2-derived IL-13 is required for activated
DCs homing to the draining lymph nodes and hence for
efficient Th2 cell priming.3 After antigen re-encounter,
ILC2-derived IL-13 within the lung also induces CCL17
production by IRF4+ CD11b+ CD103 DCs, required to
recruit memory CD4+ T cells to the inflamed lung tis-
sue.68 In the intestine, clustering of ILC3 with mononu-
clear phagocytes such as macrophages and DCs appears
to support tolerance to dietary antigens, with macro-
phage-derived IL-1b stimulating ILC3 production of
Csf-2, which is then required to promote DC support for
regulatory T cells.33,34 In addition to effects from cytokines,
cellular interactions between ILCs and antigen presenting
cells (APCs) may also shape the adaptive response. For
example NK cells can kill immature but not mature DCs
and so NK cells can help to regulate the response through
pruning of excess immature DC populations.69,70
In addition to their effects on other haematopoietic
cells, interactions between ILCs and local stroma may also
influence B-cell and T-cell responses. In ontogeny the first
known interactions of ILCs are with stromal cells, with a
RORct-expressing ILC3 population termed lymphoid tis-
sue inducer cells providing the critical source of lympho-
toxin a1b2 to stromal organizer populations and so
stimulating local stromal cell differentiation, lymphoid
tissue organogenesis and subsequent immune cell attrac-
tion.57 Marginal reticular cells comprise a subset of stro-
mal cells within secondary lymphoid tissue that closely
resemble, and are probably derived from, the embryonic
stromal organizer population.71–73 Interestingly, marginal
reticular cells are located in the same microenvironments
where RORct-expressing ILC3 have been detected, which
suggests continued interactions. In the spleen, such ILC3
interactions with marginal reticular cells are thought to
contribute to marginal zone B-cell antibody production.52
Further supporting ongoing interactions between stroma
and ILCs, ILC3 contribute to splenic tissue remodelling
after viral infection.74 Hence, it seems highly plausible
that ILC3 interactions with stromal cells may influence
stromal cell function and may contribute to the regula-
tion of lymphocytes mediated by stroma within lymphoid
tissues.75
ILCs: regulation of lymphocytes through direct
cellular interactions?
Further to the roles described above, direct cellular inter-
actions between ILCs and lymphocytes are supported by
several strands of evidence. ILC expression of MHCII,
reported on both ILC2 and ILC3, suggests interactions
specifically with CD4+ T cells and both these populations
were able to process and present model antigens
in vitro.4,5 Among ILC3, expression of MHCII appears
restricted to the CCR6+ population found predominantly
in secondary lymphoid tissue and the gut (likely within
the gut-associated lymphoid tissue).5,42 The signals gov-
erning MHCII expression on ILC3 are currently unclear,
but appear to exclude common Toll-like receptor signals
associated with driving MHCII expression on classical
ª 2016 The Authors. Immunology Published by John Wiley & Sons Ltd., Immunology, 149, 123–130126
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APCs such as macrophages and DCs.43 Furthermore,
ILC3 isolated from human small intestine also expressed
MHCII.5 ILC2 show reduced expression of MHCII
relative to ILC3 and classical APCs and its expression
appears more site specific, perhaps reflecting as yet
unknown environmental cues regulating its expression.4,5
Indirect effects via antigen presenting cells (APCs)
Direct effects
APC, e.g.
dendritic cell
Stroma 
TCRMHCII
CD4+
T cell 
ILCB cell
Cytokines
Indirect effects via stroma
Cytokines
Co-stimulation
Receptor:ligand
interactions?
Cytokine secretion?
Receptor:ligand
interactions?
Cytokine
secretion?
Receptor:ligand
interactions?
(e.g. CD28:B7
members,
TNFSF:TNFRSF
members)
Figure 2. Mechanisms through which innate lymphoid cells (ILCs) may regulate adaptive immune responses. Cartoon showing how ILC popula-
tions may interact with lymphocytes, through both direct receptor–ligand interactions [including co-stimulatory molecules such as B7 and
tumour necrosis factor superfamily (TNFSF) members], as well as indirect effects through cytokines affecting stroma and other classical antigen-
presenting cells (APCs) in the local environment.
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What do such interactions mean for CD4+ T-cell
responses? In vitro and in vivo data support MHCII-
dependent interactions between ILC2 and CD4+ T cells
that enhance the resulting CD4+ T-cell response.4,76 A
critical in vivo role for ILC3 in regulating the CD4+ T-cell
response to commensal bacteria was revealed by genetic
deletion of MHCII on ILC3 (using RORct-cre 9 H2-Ab1
floxed mice).5,43 Interestingly, loss of MHCII expression
on ILC3 in vivo (again using RORct-cre 9 H2-Ab1 floxed
mice) has also been shown to impair splenic CD4+ T-cell
responses following systemic immunization.77 Accepting
that this might reflect differences in the microbiota of
mice in distinct research facilities, these data suggest that
the consequence of ILC3–CD4+ T-cell interactions may
depend on the type and/or site of infection. MHCII
expression by ILC3 appears lower than that of DCs, sug-
gesting that ILC3 may only efficiently present high-affi-
nity peptides to CD4+ T cells. It also remains to be
determined how such peptides are acquired. Systemic
memory CD4+ T-cell responses were also substantially
impaired in mice lacking ILC3; however, it is not known
whether this effect is MHCII-dependent.40
MHCII-dependent associations obviously facilitate inter-
actions between ILC3 and specific responding CD4+ T cells,
but what mechanisms determine the outcome for the CD4+
T cell? ILC3 regulation of commensal T-cell responses may
be through sequestering available IL-2.43 Although classical
APCs are thought to provide key co-stimulatory signals to
T cells, clear evidence for co-stimulatory molecule provi-
sion from ILCs is lacking. Notably ILCs appear to express a
co-stimulatory profile distinct from classical APCs and this
is better suited to interactions with activated, rather than
naive T cells.78 Studies of ILC3 report an absence5,79 or very
low levels of CD80 and CD86,77 but expression of tumour
necrosis factor superfamily members such as lymphotoxin
a1b2, RANKL, OX40L, CD30L, LIGHT and other B7 family
members such as ICOSL all provide potential mechanisms
for ILC3 to contribute to sustaining the CD4+ T-cell
response after priming by more classical APCs.53,78–82 ILC2
also show low or undetectable expression of CD80 and
CD86,4 but do express ICOSL and also OX40L which may
impact on interactions with CD4+ T cells.83,84 One inter-
pretation of these data is that ILC–CD4+ T-cell interactions
mediated by MHCII occur subsequent to those of naive
CD4+ T cells, i.e. DC are the best cells at priming CD4+ T
cells but ILC may then regulate the resulting population.
This role is consistent with the location of these ILCs in
secondary lymphoid tissue. The specific postnatal expres-
sion of OX40L and CD30L by murine ILC3,79,81 is also sug-
gestive of a change in ILC3 function after birth. Expression
of many tumour necrosis factor superfamily members is
tightly regulated and so specific provision of ligands at cer-
tain times during the response may occur. It is clear that
for CD4+ T-cell responses, signals through OX40 and
CD30 are critical in sustaining a productive response.85,86
Given that the co-stimulatory interactions mentioned so
far impact positively on CD4+ T-cell responses, such data
must be reconciled with the regulatory role described for
ILC3 in T-cell responses to commensal bacteria, and
although effects on regulatory T cells are possible, none
have been clearly demonstrated in vivo yet.5 Of course, it is
possible that ILC provide co-
stimulatory molecules to CD4+ T cells in the absence of
MHCII-dependent interactions, as indicated for ILC2–Treg
interactions in adipose tissue.6 In addition, site-specific or
response-specific effects of ILCs on CD4+ T-cell responses
would seem entirely possible.
The role of ILCs in B-cell responses remains poorly
defined. There is evidence from human studies that sple-
nic ILC3 support marginal zone B-cell antibody produc-
tion through effects on local cell populations and perhaps
also through direct interactions.52 ILC3-dependent sup-
port for CD4+ T-cell responses will also impact on B-cell
help and there is some evidence for this in mice lacking
MHCII on ILC3.77 Effects of ILC populations on CD8+
T-cell responses have only been minimally explored and
very recent studies suggested a possible role in regulating
the homeostatic expansion of neonatal CD8+ T cells.87
Conclusions and some outstanding questions
Given their relatively recent identification and the com-
plexities of dissecting their contributions in vivo, it is hardly
surprising that many questions remain concerning the
importance of ILC populations, particularly with regard to
adaptive immune responses. Sufficient evidence indicates
that in certain situations ILC populations function to regu-
late the outcome of B-cell and T-cell responses. The chal-
lenge is to now robustly dissect the extent to which ILCs
contribute to controlling adaptive immunity and the
molecular interactions that underpin this. Armed with this
knowledge, approaches to then try to therapeutically
manipulate these pathways may reveal new ways to regulate
immune responses. In the short-term, experiments interro-
gating the following will provide key data to drive forward
the possible translation of this research:
1. What are the T-cell populations with which ILCs
interact and where do interactions occur?
2. To what extent do ILCs process and present antigen
in vivo? How is this antigen taken up and from what
sources?
3. What is the extent of cross-talk between stromal and
ILC populations and what is the outcome of these
interactions for both cell types?
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